New York Gynecologic Oncology Group

The New York Gynecologic Oncology Group (NYGOG) is a non-profit clinical research organization dedicated to the study and treatment of gynecologic cancers. Founded to facilitate collaborative research among leading medical institutions in the New York metropolitan area, NYGOG conducts multi-center clinical trials to evaluate new therapeutic strategies, including chemotherapy, targeted therapies, and immunotherapies. The group focuses on improving outcomes for patients with ovarian, endometrial, and cervical cancers through rigorous scientific investigation and clinical innovation. NYGOG serves as a bridge between academic research and clinical practice, often partnering with pharmaceutical companies and the National Cancer Institute. By leveraging the collective expertise of its member institutions, the group aims to improve survival rates and quality of life for women diagnosed with reproductive tract cancers.